Suppr超能文献

中枢性甲状腺功能减退患者的促甲状腺激素分泌:免疫反应性促甲状腺激素生物活性降低的证据。

Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin.

作者信息

Faglia G, Bitensky L, Pinchera A, Ferrari C, Paracchi A, Beck-Peccoz P, Ambrosi B, Spada A

出版信息

J Clin Endocrinol Metab. 1979 Jun;48(6):989-98. doi: 10.1210/jcem-48-6-989.

Abstract

TSH concentration was measured in plasma before and after TRH administration (200 micrograms, iv) in 89 patients with documented hypothyroidism consequent to various hypothalamic-pituitary disorders. Basal plasma TSH was less than 1.0 microI/ml in 34.8%, between 1.0-3.6 microU/ml in 40.5% and slightly elevated (3.7-9.7 microU/ml) in 24.7% of the cases. The plasma TSH response to TRH was absent in 13.5%, impaired in 16.8%, normal in 47.2%, and exaggerated in 22.5% of the cases, with delayed and/or prolonged pattern of response in 65% of the cases. The dilution curves of several plasmas drawn before and after TRH were parallel to those obtained with TSH standard preparation. After gel filtration, the elution pattern of TRH-stimulated plasmas from 4 patients did not show any major difference from that of pooled plasmas from normal subjects given TRH or from that of patients with primary hypothyroidism. Plasma TSH values determined by cytochemical bioassay on both basal and TRH-stimulated samples of 5 patients were markedly lower than those obtained by RIA. The serum T3 response to TRH was absent or low in 40 out of 53 patients in whom it was evaluated. The administration of T3 (100 micrograms/day for 3 days) or dexamethasone (3 mg/day for 5 days) respectively suppressed or reduced both basal and TRH-induced plasma TSH levels. Two patients became hypothyroid shortly after pituitary surgery in spite of basal and TRH-induced plasma TSH levels similar to or higher than those before surgery. Though thyroid atrophy due to chronic understimulation could explain the low T3 response to TRH in secondary hypothyroidism, it is difficult to reconcile thyroid understimulation with normal or increased plasma TSH unless the immunoreactive material has low biological activity. Present data suggest that several patients with hypothyroidism consequent to hypothalamic-pituitary diseases secrete a material which is immunologically similar to pituitary standard TSH and responds to stimulatory and suppressive agents in a manner similar to normal TSH but has low or absent biological activity. Thus, hypothyroidism due to insufficient TSH stimulation can be termed central hypothyroidism and can be due 1) to pituitary insufficiency (secondary hypothyroidism), 2) to a hypothalamic defect (tertiary hypothyroidism), or 3) to the secretion of biologically inactive TSH.

摘要

在89例因各种下丘脑 - 垂体疾病导致甲状腺功能减退的患者中,静脉注射促甲状腺激素释放激素(TRH,200微克)前后测定血浆促甲状腺激素(TSH)浓度。基础血浆TSH在34.8%的病例中低于1.0微国际单位/毫升,在40.5%的病例中介于1.0 - 3.6微国际单位/毫升之间,在24.7%的病例中轻度升高(3.7 - 9.7微国际单位/毫升)。血浆TSH对TRH的反应在13.5%的病例中缺失,在16.8%的病例中受损,在47.2%的病例中正常,在22.5%的病例中亢进,65%的病例反应延迟和/或延长。TRH注射前后采集的几份血浆的稀释曲线与用TSH标准制剂获得的曲线平行。凝胶过滤后,4例患者经TRH刺激后的血浆洗脱模式与给予TRH的正常受试者混合血浆或原发性甲状腺功能减退患者的血浆洗脱模式无明显差异。5例患者基础和TRH刺激样本经细胞化学生物测定法测定的血浆TSH值明显低于放射免疫分析法测得的值。在53例评估血清三碘甲状腺原氨酸(T3)对TRH反应的患者中,40例无反应或反应低下。分别给予T3(100微克/天,共3天)或地塞米松(3毫克/天,共5天)可分别抑制或降低基础和TRH诱导的血浆TSH水平。2例患者垂体手术后不久出现甲状腺功能减退,尽管基础和TRH诱导的血浆TSH水平与手术前相似或更高。虽然继发性甲状腺功能减退中由于慢性刺激不足导致的甲状腺萎缩可以解释对TRH的低T3反应,但除非免疫反应性物质生物活性低,否则很难将甲状腺刺激不足与正常或升高的血浆TSH相协调。目前的数据表明,一些因下丘脑 - 垂体疾病导致甲状腺功能减退的患者分泌一种在免疫学上与垂体标准TSH相似的物质,其对刺激剂和抑制剂的反应方式与正常TSH相似,但生物活性低或无生物活性。因此,由于TSH刺激不足导致的甲状腺功能减退可称为中枢性甲状腺功能减退,其原因可能为:1)垂体功能不全(继发性甲状腺功能减退);2)下丘脑缺陷(三级甲状腺功能减退);3)分泌无生物活性的TSH。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验